About a year ago, the first psychedelics-focused exchange-traded funds were debited on Toronto’s NEO exchange. The ETF, Horizons Psychedelic Stock Index (NEO: PSYK), was launched to focus on the relatively new industry. Less than six months after this launch, Defiance ETF launched the Defiance Next Gen Altered Experience in the U.S. Due to the low-key state of the industry then, both ETFs remained passive and focused on tracking a periodically restructured index. The only active ETF in the U.S. psychedelic sector is the AdvisorShares Psychedelics ETF, launched in September by AdvisorShares.